Launches of Tuzulby® methylphenidate prolonged-release chewable tablets and Paxneury® guanfacine prolonged-release tablets, also in 5mg, 6mg, and 7mg strengthsTwo differentiated treatments exemplify ...

German CNS-focused specialist Neuraxpharm Group announced the launches in Europe of Tuzulby (methylphenidate hydrochloride) prolonged-release chewable tablets and Paxneury (guanfacine) ...

There are concerns that the drugs are being misused for academic performance. Read more at straitstimes.com. Read more at ...

After evaluating scans of almost 5,800 children with and without attention deficit disorder, US researchers discovered that ...

Prescriptions for methylphenidate, a central nervous system stimulant primarily used to treat attention deficit hyperactivity ...

Attention-deficit/hyperactivity disorder (ADHD) affects 3%–5% of children and about 2.5% of adults, though prevalence varies ...

UCT/MRC Research Unit for Exercise Science and Sports Medicine, Department of Human Biology, University of Cape Town, Sports Science Institute of South Africa, Newlands, South Africa Objective: The ...

Concerta and Adderall are medicines children and adults can take to manage their ADHD symptoms. They're both stimulants -- the most common type of drug used to treat the disorder. All stimulant drugs ...

- Methylphenidate might reduce hyperactivity and impulsivity and might help children to concentrate. Methylphenidate might also help to improve general behaviour, but does not seem to affect quality ...

The number of people receiving medication for ADHD under free or subsidised drug schemes has surged by 150% since the beginning of the covid pandemic, costing more than €30m in the past five years. A ...

The presence of dysregulation profile in children with ADHD was associated with higher sleep disturbances following treatment with methylphenidate. Children with ...